| Literature DB >> 26739481 |
Michel Maitre1, Christian Klein1, Ayikoe G Mensah-Nyagan1.
Abstract
γ-Hydroxybutyrate (GHB) is both a natural brain compound with neuromodulatory properties at central GABAergic synapses (micromolar concentration range) and also a drug (Xyrem(R) ) clinically used for the treatment of various neurological symptoms (millimolar dose range). However, this drug has abuse potential and can be addictive for some patients. Here, we review the basic mechanistic role of endogenous GHB in brain as well as the properties and mechanisms of action for therapeutic clinical doses of exogenous GHB. Several hypotheses are discussed with a preference for a molecular mechanism that conciliates most of the findings available. This conciliatory model may help for the design of GHB-like drugs active at lower doses and devoid of major side effects.Entities:
Keywords: GHB; gamma-hydroxybutyrate; mechanisms of action; therapeutic doses; xyrem
Mesh:
Substances:
Year: 2016 PMID: 26739481 DOI: 10.1002/med.21382
Source DB: PubMed Journal: Med Res Rev ISSN: 0198-6325 Impact factor: 12.944